Resistance Oncology ApS — Credit Rating and Financial Key Figures

CVR number: 36945125
Amaliegade 13, 1256 København K
tel: 30428597

Income statement (kDKK)

2020
2021
2022
2023
2024
Fiscal period length1212121212
Net sales
Gross profit-9.50-10.14-11.97-21.00-15.71
EBIT-9.50-10.14-11.97-21.00-15.71
Other financial income0.060.050.20
Other financial expenses-0.35-0.91-1.17-6.09-8.40
Net income from associates (fin.)-0.93-10.39
Pre-tax profit-9.79-11.04-13.14-27.98-34.31
Income taxes2.142.432.895.955.26
Net earnings-7.65-8.62-10.25-22.03-29.05

Assets (kDKK)

2020
2021
2022
2023
2024
Intangible assets total
Tangible assets total
Holdings in group member companies39.07308.68
Investments total39.07308.68
Long term receivables total
Inventories total
Prepayments and accrued income1.02
Current other receivables2.372.192.490.572.56
Current deferred tax assets2.152.432.895.955.26
Short term receivables total4.534.625.387.547.82
Cash and bank deposits1.961.481.442.55131.12
Cash and cash equivalents1.961.481.442.55131.12
Balance sheet total (assets)6.496.106.8249.16447.62

Equity and liabilities (kDKK)

2020
2021
2022
2023
2024
Share capital51.0051.0051.0051.0051.00
Retained earnings-65.91-73.56-82.18-92.43285.54
Profit of the financial year-7.65-8.62-10.25-22.03-29.05
Shareholders equity total-22.56-31.18-41.43-63.46307.49
Non-current liabilities total
Current trade creditors9.008.009.009.5010.75
Current owed to group member20.0529.2839.25103.12129.38
Current liabilities total29.0537.2848.25112.62140.13
Balance sheet total (liabilities)6.496.106.8249.16447.62
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.